Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy
about
Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical ApplicationsImpact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathiesCardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic CardiomyopathyRole of cardiac MRI in the assessment of nonischemic cardiomyopathiesArrhythmia risk stratification of patients after myocardial infarction using personalized heart modelsLate Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.The case for CMR.Role of Cardiac MR Imaging in CardiomyopathiesPractical applications of cardiovascular magnetic resonance.Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis.Emerging MRI methods in translational cardiovascular researchCardiovascular magnetic resonance: applications in daily practice.Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies.Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.Applications of cardiac magnetic resonance in electrophysiology.Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis.Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy.Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial.Ex-vivo Assessment of Coronary Artery Atherosclerosis by Magnetic Resonance Imaging: Correlation with Histopathology.Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.Comparison of the relation between left ventricular anatomy and QRS duration in patients with cardiomyopathy with versus without left bundle branch block.Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathyCardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis.The natural history of acute dilated cardiomyopathy.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy.An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialBaseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion.Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.Cardiac imaging in evaluating patients prone to sudden deathPrognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.Early identification of risk factors for sudden cardiac death.Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operationAssessment of myocardial fibrosis with cardiovascular magnetic resonance.T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.
P2860
Q26749269-55DD3755-6495-456C-9144-E0EAB65DFF2EQ26765173-FDA3B738-AE5D-4D20-8988-B84D2C7AEE1CQ26801712-2D69EA60-703C-4F04-91CB-A90C15A601FBQ26998997-2F33B9E1-C3A1-4A9A-BBCE-A257A52A7BA9Q27318488-E7A2272B-1082-498A-B877-CAC0B77A0E77Q30251600-F40336C3-728E-4E77-8D1F-72E5322BA9C1Q30279054-A4FA3EFA-974E-4232-AA89-445D93151631Q30279246-6CF26E91-B329-47C3-B814-9C3388ACD0EEQ30381191-6A30006D-87E7-4BFD-8E64-59968CA135E8Q30407667-8017B181-3324-4867-9CB7-6FBD4D879384Q30411158-9D7E0BF8-87B2-4983-85E4-A4F4A2B44F1FQ30425743-43C84142-8383-4D74-97D1-64E9107AFBE0Q30430740-6032EC15-D560-4952-8363-FA49C51BF531Q30432814-353E776E-3CEB-4E5D-991B-B432A9F8AF74Q30434270-CE25172F-E1FE-4043-9FAE-4197D5BADD96Q30463822-EF33862C-26D0-444D-90FB-A818C34A8315Q30464771-4D951A1A-1D63-4FFC-A935-921A7B143584Q30573820-C882B1C6-4AD6-41E4-9D6A-7AF43A8BA444Q30797017-5EBF2C87-AED0-49E6-9506-5A37C2628B9EQ33168179-B496B4F8-5D1F-48E8-A14C-D5E8B26F6205Q33612030-887E3E6F-A1FE-41D9-AC4F-4BFFF056C734Q33711320-05A353A3-7DFE-4829-92CC-9CE16AD9ADFCQ33732461-342BB018-139D-4D7D-96AB-F6772C8472C9Q33822332-2887C251-2084-40F4-9887-6F8EE2DBB13CQ33912880-3B66F2B2-81E8-4EE7-AFD7-493A5F0557F8Q33957691-5A4196A0-91DE-430E-949A-220A982F5CBFQ34028344-DAB34BF4-1636-4EB2-90EF-4345511DAE8FQ34051551-7B1954F9-4899-4823-B61F-F6186DC4FFD5Q34130016-36EAB465-7618-48FB-9E3A-521104A2344DQ34274471-F69FFD83-AFBA-4A9B-9413-104DA6416750Q34441831-F14F5A5A-05D4-4A64-A4EE-931C804389C9Q34484945-C43CC594-7716-4114-A972-8B185A7554C2Q34498658-F2E6F763-F916-4D55-BC8A-C1928ECFAF1CQ34518419-FA90ACC0-84E3-497A-9D9F-89853B9C9512Q34541844-7FB4EE90-3A09-43D6-A4AE-42FE582D887EQ34600002-DD88B54C-2CB7-4503-99A6-747B4E3EABF3Q34640857-4AF97BA2-F45A-43D2-AA79-862AF9ED7FACQ34702433-F43C2669-EC4E-4C26-93A1-373B1BEC1D20Q34846884-D0BE6379-2897-4895-9B03-28E02BE114AAQ34975574-A9B02DD5-8E1F-4986-923C-7BDC42A5EC5A
P2860
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@ast
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@en
type
label
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@ast
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@en
prefLabel
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@ast
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@en
P2093
P2860
P1476
Late gadolinium enhancement by ...... in nonischemic cardiomyopathy
@en
P2093
André Schmidt
Darshan Dalal
David R Thiemann
Eduardo Marbán
Gary Gerstenblith
Gordon F Tomaselli
João A C Lima
Kakuya Kitagawa
Katherine C Wu
Robert G Weiss
P2860
P304
P356
10.1016/J.JACC.2008.03.018
P407
P577
2008-06-01T00:00:00Z